查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496002

血管造影術設備市場 – 2024 年至 2029 年預測

Angiography Equipment Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2022年血管造影術設備市值為149.02億美元，預計複合年成長率為8.42%，到2029年達到262.36億美元。

血管造影術是一種用於可視化血管並評估血流的醫療技術。顯影劑注入血管並拍攝 X 光影像以獲得詳細影像。傳統血管造影術使用電離輻射，而數位減影血管造影術則提高了可視性。螢光檢查系統使用連續的 X光束，可以獲得即時影像。

使用碘基或新型顯影劑。非侵入性方法包括電腦斷層掃描 (CTA)、磁振造影血管攝影 (MRA)、超音波系統和血流動力學監測系統。先進的血管造影術設備包括 3D 重建軟體。全球癌症和心血管疾病盛行率上升是預計在預測期內推動血管造影術設備市場成長的關鍵因素之一。

老年人和肥胖人口的增加導致需要血管造影術的疾病迅速增加。此外，各新興市場有關產品核可的有利政府法規也預計將推動全球市場的成長。此外，對微創手術偏好的改變也增加了對血管造影術系統的需求。

此外，血管造影術設備的技術創新和醫療流程的改進預計將有助於市場成長。然而，採購和使用技術先進的血管造影術設備的高成本是可能阻礙全球市場成長的主要因素。

市場促進因素：

  • 心血管疾病盛行率的增加預示著市場的成長

在全球範圍內，心血管疾病患者的數量多年來一直在迅速增加，這導致對血管造影術設備的需求增加，預計將在預測期內推動市場成長。根據《美國心臟病學會雜誌》2020 年 12 月發表的一篇論文，1990 年有 2.7 億人患有心血管疾病，2019 年這一數字幾乎加倍，達到 5.23 億。死於心血管疾病的人數從1990年的1,210萬人增加到2019年的1,860萬人。

美國心臟協會 (AHA) 預測，45% 的美國將至少患有一種與心臟相關的問題。它還估計，2016 年至 2035 年間，與心血管疾病相關的費用將增加 100%。據世界衛生組織稱，心血管疾病在主要死亡原因中所佔比例最高。

該組織稱，2019年，心血管疾病導致全球1,790萬人死亡，佔全球死亡人數的32%。隨著心臟病盛行率的增加，過早死亡也在增加，2019 年因非傳染性疾病導致的 1,700 萬人過早死亡中，CVD 佔 38%。 CVD 的成長趨勢預計將在未來幾年持續，並有望推動血管造影術設備市場的成長。

  • 不斷增加的技術創新可能會增強血管造影術設備市場。

血管造影術設備市場不斷成長的技術創新以及市場參與者推出先進的血管造影術設備預計將擴大血管造影術設備的範圍並推動血管造影術設備在評估期內的成長。醫療設備製造商Kinepict Health開發了Kinepict醫療影像工具（KMIT）軟體，該軟體採用DVA（數位變異數血管攝影）技術。

2020年3月獲得FDA批准，允許其在美國市場上市。此外，GE Healthcare 在北美放射學會 (RSNA) 2020 虛擬會議上宣布推出 Allia IGS 7血管造影術系統。該系統使用人工智慧，可以更好地利用旋轉血管造影術。

多家公司推出了其他改善血管造影術流程的創新產品，預計將在預測期內推動血管造影術設備的成長。

北美地區佔據主要市場佔有率。

由於許多市場領導的存在以及心血管疾病的高盛行率，預計北美地區將佔據很大的市場佔有率。此外，先進的醫療保健系統的存在導致了新型血管造影術設備的採用。

隨著心血管疾病病例數量的增加以及對該地區醫療保健部門的投資增加，預計該地區將顯著成長，從而提供必要的醫療設施。

主要進展

  • 西門子 Healthineers 推出了 Atellica CI 分析儀，這是一款旨在解決實驗室挑戰的緊湊型測試系統。這款經 FDA 批准的分析儀提供可預測的交付時間、先進的報告功能和安全措施。它適用於中低測試量，目前在許多主要市場都有售。西門子 Healthineers 還推出了 Atellica Vantage 640 心血管血管造影術系統，該系統可為複雜的心臟手術提供卓越的影像品質並縮短掃描時間。飛利浦醫療保健公司的 Azurion Clarity 3D血管造影術系統可提供即時血管 3D 影像，而 GE 醫療保健公司的 Discovery™ HI FX40血管造影術系統可提供低劑量的高品質影像。
  • 2023 年 5 月 - GE Healthcare 的 Voluson(TM) Expert 22 在第七屆年度醫療技術突破獎上被評為「最佳新型超音波技術解決方案」。該設備採用基於圖形的自我調整波束形成器和人工智慧，每年在美國協助超過 360 萬人出生。其 Lyric架構可實現即時資料處理並提供更清晰的 2D/3D/4D 成像。它還具有方便用戶使用的觸控螢幕顯示器、簡單的控制以及具有三種圖像尺寸的高清超音波監視器。
  • 2022年11月－Canon引進紅仁科技先進技術，開發出國內首個光子計數CT（PCT）系統。該設備將安裝在國家癌症中心癌症研究和臨床臨床實驗中心，用於PCT臨床應用的研究。該系統配備了基於 Redren Technologies 開發的最新結晶製造和加工技術的先進模組化光子計數檢測器，可在增加尺寸的同時降低製造和服務成本。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章血管造影術設備市場：依技術分類

  • 介紹
  • X血管造影術
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 血管造影術
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 血管造影術
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章血管造影術設備市場：依程序

  • 介紹
  • 冠狀動脈
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 血管內的
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 神經血管的
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章血管造影術設備市場：按應用

  • 介紹
  • 診斷
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 治療
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第8章血管造影術設備市場：依最終用戶分類

  • 介紹
  • 醫院/診所
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 研究機構
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 診斷中心
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第9章血管造影術設備市場：按地區

  • 介紹
  • 北美洲
    • 依技術
    • 透過治療
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 依技術
    • 透過治療
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 依技術
    • 透過治療
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 依技術
    • 透過治療
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 依技術
    • 透過治療
    • 按用途
    • 按最終用戶
    • 按國家/地區

第10章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第11章 公司簡介

  • GE Healthcare
  • Siemens Healthcare
  • Philips Healthcare
  • Shimadzu Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cordis Corporation
  • AngioDynamics, Inc.
簡介目錄
Product Code: KSI061611893

The angiography equipment market is evaluated at US$14.902 billion for 2022 and is projected to grow at a CAGR of 8.42% to reach US$26.236 billion by 2029.

Angiography is a medical technique used to visualize blood vessels and assess blood flow. It involves injecting a contrast agent into blood vessels and capturing X-ray images to obtain detailed images. Traditional angiography uses ionizing radiation, while Digital Subtraction Angiography enhances visibility. Fluoroscopy systems use continuous X-ray beams for real-time images.

Contrast agents, such as iodine-based or newer ones, are used. Non-invasive alternatives include Computed Tomography Angiography (CTA), Magnetic Resonance Angiography (MRA), ultrasound systems, and hemodynamic monitoring systems. Advanced angiography equipment includes 3D reconstruction software. The high prevalence, coupled with the increasing incidence of cancer and cardiovascular diseases around the world, is one of the major factors anticipated to drive the angiography equipment market growth during the forecast period.

The rise in the geriatric population and an increase in the growing number of obese people worldwide are leading to a surge in diseases that require angiography. Furthermore, favorable government regulations for the approval of the product in the various developed regions are also expected to fuel the growth of the global market. There is also a growing demand for angiography systems due to a shift in preference toward minimally invasive surgeries.

Moreover, growing innovations in angiography equipment are improving the medical process and, hence, are anticipated to contribute to the market growth. However, high costs associated with the procurement and use of technologically advanced angiography equipment are major factors likely to hamper the global market growth.

Market Drivers:

  • The increasing prevalence of cardiovascular diseases is anticipated in the market growth

The world has witnessed a surge in the number of cases of cardiovascular diseases over the years, which is leading to an increased demand for angiography equipment and is projected to boost market growth during the forecast period. A paper in the Journal of the American College of Cardiology stated in December 2020 that there were 270 million cases of cardiovascular diseases in 1990, which nearly doubled to 523 million in 2019. It also states that the number of people who died from cardiovascular disease increased from 12.1 million in 1990 to 18.6 million in 2019.

The American Heart Association (AHA) predicts that 45% of the population of the United States will have at least one heart-related problem. It also estimates that the costs related to cardiovascular diseases will increase by 100% between 2016 and 2035. According to WHO, cardiovascular disease has the highest share in the list of leading causes of death.

The organization states that cardiovascular diseases caused 17.9 million deaths in 2019 around the world and represented 32% of all deaths worldwide. Premature deaths are also increasing with the growing prevalence of heart diseases, with 38% of all the 17 million premature deaths due to non-communicable diseases caused by CVDs in 2019. The growing trend of CVDs is projected to continue in the coming years as well and is anticipated to drive the market growth of angiography equipment.

  • An increase in innovation would bolster the angiography equipment market.

The rising innovations in the market and the launch of advanced angiography equipment by the market players are widening the scope of angiography equipment and are anticipated to propel the growth of angiography equipment during the assessment period. The medical device company Kinepict Health has developed Kinepict Medical Imaging Tool (KMIT) software which uses Digital Variance Angiography (DVA) technology and provides superior image quality compared to the conventionally used technologies.

The FDA has given clearance for it in March 2020, allowing it to be launched in the U.S. market. Furthermore, GE Healthcare introduced the Allia IGS 7 angiography system at the Radiological Society of North America (RSNA) 2020 virtual meeting. The system uses artificial intelligence and allows better use of rotational angiography.

Various companies are launching several other innovative products that will improve the angiography process and are anticipated to spur the growth of angiography equipment during the forecast period.

North America region held a significant market share.

The North American region is anticipated to hold a significant market share owing to the presence of a large number of market leaders, coupled with a high prevalence of cardiovascular diseases. The presence of an advanced healthcare system also allows a larger adoption of new and advanced angiography equipment.

The region is anticipated to witness substantial growth due to the rising number of cases of CVDs, coupled with increased investments in the healthcare sector in the region, which will lead to the availability of requisite healthcare facilities.

Key Developments:

  • July 2023- Siemens Healthineers introduced the Atellica CI Analyzer, a compact testing system designed to address lab challenges. The FDA-cleared analyzer offers improved turnaround time predictability, advanced reporting functionality, and safety measures. It is suitable for low to medium testing volumes and is now available in many major markets. Siemens Healthineers also launched the Atellica Vantage 640 Cardiac Angiography System, which offers superior image quality and faster scan times for complex cardiac procedures. Philips Healthcare's Azurion Clarity 3D angiography system provides real-time 3D images of blood vessels, while GE Healthcare's Discovery(TM) HI FX40 angiography system offers high-quality images at low radiation doses.
  • May 2023- GE HealthCare's Voluson(TM) Expert 22 was named the "Best New Ultrasound Technology Solution" at the seventh annual MedTech Breakthrough Awards. The device, which uses an adaptive graphic-based beamformer and artificial intelligence, aids in over 3.6 million live births annually in the US. Its Lyric Architecture enables real-time data processing, resulting in sharper imaging in 2D/3D/4D. The device also features a user-friendly touch panel display, simple controls, and a high-definition ultrasound monitor with three image sizes. Clinicians can personalize the display and controls with exterior lighting colors, trackballs, and hard and soft keys.
  • November 2022- Canon Inc. developed the first domestically produced photon-counting CT (PCCT) system, incorporating Redlen Technologies Inc.'s advanced technologies. The system, installed at the National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center, is used for research exploring the clinical applications of PCCT. The system features an advanced modular photon-counting detector based on the latest crystal production/processing technologies developed by Redlen Technologies Inc., which allows for increased size while reducing manufacturing and service costs.

Market Segmentation:

By Technology

  • X-Ray Angiography
  • Computed Tomography Angiography
  • Magnetic Resonance Angiography

By Procedure

  • Coronary
  • Endovascular
  • Neurovascular

By Application

  • Diagnostic
  • Therapeutic

By End-User

  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ANGIOGRAPHY EQUIPMENT MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. X-Ray Angiography
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Computed Tomography Angiography
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Magnetic Resonance Angiography
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness

6. ANGIOGRAPHY EQUIPMENT MARKET BY PROCEDURE

  • 6.1. Introduction
  • 6.2. Coronary
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Endovascular
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Neurovascular
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. ANGIOGRAPHY EQUIPMENT MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Diagnostic
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Therapeutic
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. ANGIOGRAPHY EQUIPMENT MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
    • 8.2.1. Market Opportunities and Trends
    • 8.2.2. Growth Prospects
    • 8.2.3. Geographic Lucrativeness
  • 8.3. Research Institutes
    • 8.3.1. Market Opportunities and Trends
    • 8.3.2. Growth Prospects
    • 8.3.3. Geographic Lucrativeness
  • 8.4. Diagnostic Centers
    • 8.4.1. Market Opportunities and Trends
    • 8.4.2. Growth Prospects
    • 8.4.3. Geographic Lucrativeness

9. ANGIOGRAPHY EQUIPMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Technology
    • 9.2.2. By Procedure
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
        • 9.2.5.1.1. Market Opportunities and Trends
        • 9.2.5.1.2. Growth Prospects
      • 9.2.5.2. Canada
        • 9.2.5.2.1. Market Opportunities and Trends
        • 9.2.5.2.2. Growth Prospects
      • 9.2.5.3. Mexico
        • 9.2.5.3.1. Market Opportunities and Trends
        • 9.2.5.3.2. Growth Prospects
  • 9.3. South America
    • 9.3.1. By Technology
    • 9.3.2. By Procedure
    • 9.3.3. By Application
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
        • 9.3.5.1.1. Market Opportunities and Trends
        • 9.3.5.1.2. Growth Prospects
      • 9.3.5.2. Argentina
        • 9.3.5.2.1. Market Opportunities and Trends
        • 9.3.5.2.2. Growth Prospects
      • 9.3.5.3. Others
        • 9.3.5.3.1. Market Opportunities and Trends
        • 9.3.5.3.2. Growth Prospects
  • 9.4. Europe
    • 9.4.1. By Technology
    • 9.4.2. By Procedure
    • 9.4.3. By Application
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
        • 9.4.5.1.1. Market Opportunities and Trends
        • 9.4.5.1.2. Growth Prospects
      • 9.4.5.2. France
        • 9.4.5.2.1. Market Opportunities and Trends
        • 9.4.5.2.2. Growth Prospects
      • 9.4.5.3. UK
        • 9.4.5.3.1. Market Opportunities and Trends
        • 9.4.5.3.2. Growth Prospects
      • 9.4.5.4. Spain
        • 9.4.5.4.1. Market Opportunities and Trends
        • 9.4.5.4.2. Growth Prospects
      • 9.4.5.5. Others
        • 9.4.5.5.1. Market Opportunities and Trends
        • 9.4.5.5.2. Growth Prospects
  • 9.5. Middle East and Africa
    • 9.5.1. By Technology
    • 9.5.2. By Procedure
    • 9.5.3. By Application
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
        • 9.5.5.1.1. Market Opportunities and Trends
        • 9.5.5.1.2. Growth Prospects
      • 9.5.5.2. UAE
        • 9.5.5.2.1. Market Opportunities and Trends
        • 9.5.5.2.2. Growth Prospects
      • 9.5.5.3. Others
        • 9.5.5.3.1. Market Opportunities and Trends
        • 9.5.5.3.2. Growth Prospects
  • 9.6. Asia Pacific
    • 9.6.1. By Technology
    • 9.6.2. By Procedure
    • 9.6.3. By Application
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
        • 9.6.5.1.1. Market Opportunities and Trends
        • 9.6.5.1.2. Growth Prospects
      • 9.6.5.2. India
        • 9.6.5.2.1. Market Opportunities and Trends
        • 9.6.5.2.2. Growth Prospects
      • 9.6.5.3. Japan
        • 9.6.5.3.1. Market Opportunities and Trends
        • 9.6.5.3.2. Growth Prospects
      • 9.6.5.4. South Korea
        • 9.6.5.4.1. Market Opportunities and Trends
        • 9.6.5.4.2. Growth Prospects
      • 9.6.5.5. Taiwan
        • 9.6.5.5.1. Market Opportunities and Trends
        • 9.6.5.5.2. Growth Prospects
      • 9.6.5.6. Thailand
        • 9.6.5.6.1. Market Opportunities and Trends
        • 9.6.5.6.2. Growth Prospects
      • 9.6.5.7. Indonesia
        • 9.6.5.7.1. Market Opportunities and Trends
        • 9.6.5.7.2. Growth Prospects
      • 9.6.5.8. Others
        • 9.6.5.8.1. Market Opportunities and Trends
        • 9.6.5.8.2. Growth Prospects

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. GE Healthcare
  • 11.2. Siemens Healthcare
  • 11.3. Philips Healthcare
  • 11.4. Shimadzu Corporation
  • 11.5. Canon Medical Systems Corporation
  • 11.6. Carestream Health
  • 11.7. B. Braun Melsungen AG
  • 11.8. Boston Scientific Corporation
  • 11.9. Cordis Corporation
  • 11.10. AngioDynamics, Inc.